Insider · CIK 0001749860
Merle Ferguson
Files at BFNH (BIOFORCE NANOSCIENCES HOLDINGS, INC.). First filing Sep 2, 2026, latest Sep 2, 2026.
In brief
Merle Ferguson files SEC Form 4 as director, CEO and 10% owner at BFNH (BIOFORCE NANOSCIENCES HOLDINGS, INC.). Since Sep 2, 2026, Merle Ferguson has reported 0 open-market buys worth $0 and 1 open-market sell worth $401k, the latest filed on Sep 2, 2026.
A track record needs three past buys with six months of prices behind them; Merle Ferguson has 0, so none is measured yet.
The newest scored trade: sold $401k of BFNH on Apr 22, 2026, filed Sep 2, 2026, scored 51 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $401k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BFNH: BIOFORCE NANOSCIENCES HOLDINGS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | BFNHsell BIOFORCE NANOSCIENCES HOLDINGS, INC. | $401k 26,700,000 shares | -100% | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. | GGift Common Stock; Par Value $0.001 | +20,580,000 | $0.01 | $144k | 22,568,000 | 41 d ago |
| Apr 20, 2026 | BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. | GGift Common Stock; Par Value $0.001 | +4,132,000 | $0.00 | $4,132 | 26,700,000 | 41 d ago |
| Apr 22, 2026 | BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. | SOpen-market sale Common Stock; Par Value $0.001 | -26,700,000 | $0.02 | $401k | 0 | 41 d ago |
| Oct 17, 2023 | BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. | GGift Common Stockindirect: Shares Held in Private Company | -1,470,000 | $0.00 | $0 | 15,000,000 | Oct 18, 2023 |
| May 12, 2023 | BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. | GGift Common Stockindirect: Shares Held in Private Company | -500,000 | $0.00 | $0 | 16,470,000 | Oct 18, 2023 |
| Oct 17, 2023 | BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. | GGift Common Stock | +1,470,000 | $0.00 | $0 | 16,470,000 | Oct 18, 2023 |
| Oct 18, 2023 | BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. | GGift Common Stock | +1,400,000 | $0.00 | $0 | 17,870,000 | Oct 18, 2023 |
Questions about Merle Ferguson
Answered from the filings on this page, as of the latest one.
Is Merle Ferguson buying or selling?
In the last 12 months Merle Ferguson reported 0 open-market buys worth $0 and 1 open-market sell worth $401k on SEC Form 4; the latest was sold $401k of BFNH on Apr 22, 2026. Grants, option exercises and tax withholding are not counted.
How did Merle Ferguson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Merle Ferguson has 0.
Where does Merle Ferguson file Form 4?
Merle Ferguson has filed Form 4 at BFNH (BIOFORCE NANOSCIENCES HOLDINGS, INC.) as CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.